Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RNA Australia is a biotechnology company and national initiative dedicated to establishing a sovereign RNA manufacturing and research ecosystem in Australia. Headquartered in Sydney and closely affiliated with the University of New South Wales (UNSW), the company facilitates the development of mRNA-based therapeutics and vaccines through its pilot-scale manufacturing capabilities. It operates as a central hub for the Australian RNA Production Network (ARPN), connecting academic researchers with industry partners to accelerate the translation of RNA technologies. The organization focuses on providing high-quality RNA materials, lipid nanoparticle (LNP) formulation services, and technical expertise to support clinical trials and commercialization efforts. By bridging the gap between discovery and production, RNA Australia plays a critical role in the Australian life sciences landscape. Its facilities are designed to support the rapid prototyping and scale-up of RNA candidates for a variety of therapeutic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RNA Australia.